UPDATE : Wednesday, January 17, 2018
상단여백
Customized subfertility therapy to debut in Korea
REKOVELLE (compound: follitropin delta), the personalized subfertility trea...
by Lee Hye-seon  |  2017-04-26 16:22
라인
FDA warns 14 firms against selling false cancer-curing products
The U.S. Food and Drug Administration (FDA) posted warning letters on Tuesd...
by Constance Williams  |  2017-04-26 10:49
라인
Samsung Bioepis wins first FDA approval for biosimilar drug
The U.S. Food and Drug Administration Friday approved Samsung Bioepis’ rheu...
by Marian Chu  |  2017-04-24 18:18
라인
Pharmacists oppose introduction of corporate-style drugstores
Koreans work hard. They are second-hardest working people among OECD nation...
by Constance Williams  |  2017-04-21 16:51
라인
Baxter allegedly forces workers to quit under disguise of advice
Baxter Korea, the Korean offshoot of the U.S.-based pharmaceutical company,...
by Marian Chu  |  2017-04-20 16:17
라인
Daewoong launches first generic antibiotic in US
Daewoong Pharmaceutical대웅제약 has launched its generic antibiotic “Meropenem”...
by Constance Williams  |  2017-04-19 18:03
라인
State auditors ‘fail to confirm Hanmi’s cover-up of clinical results’
The government’s top administrative watchdog has found Hanmi Pharmaceutical...
by Marian Chu  |  2017-04-18 15:23
라인
FDA stuns Eli-Lilly, Incyte by rejecting rheumatoid arthritis drug
Eli Lilly and Co. and Incyte Corp. said Friday that the U.S. Food and Drug ...
by Constance Williams  |  2017-04-17 17:17
라인
Cancer patients protest against Novartis Korea
Novartis Korea’s targeted anticancer treatment, Gleevec, is in danger of lo...
by Marian Chu  |  2017-04-17 15:04
라인
Korean firms stage ‘let’s-save-our drug’ drive
The “let’s-save-our drug” campaign -- initiated by the domestic medicine di...
by Lee Hye-seon  |  2017-04-14 15:30
라인
Hanmi preempts global incontinence drug market
Hanmi Pharma한미약품(CEOs Woo Jong-soo우종수 and Kwon Se-chang권세창) has grabbed ano...
by Lee Hye-seon  |  2017-04-12 18:37
라인
FDA approves first drug for tardive dyskinesia
The U.S. Food and Drug Administration (FDA) said Tuesday it approved Ingrez...
by Constance Williams  |  2017-04-12 16:11
라인
KPAC 2017 focuses on ‘open innovation’ by pharma industry
Korean and foreign pharmaceutical companies got together at the Korea Pharm...
by Marian Chu  |  2017-04-11 18:52
라인
FDA rejects Merck’s bid to expand Januvia label
Merck & Co. said the U.S. FDA had rejected its additional non-disclosure ag...
by Constance Williams  |  2017-04-11 11:39
라인
Hanmi makes public 23 new drug pipelines on its website
Hanmi Pharm한미약품 (CEO Kwon Se-Chang권세창 and Woo Jong-soo우종수), announced 23 ne...
by Marian Chu  |  2017-04-10 18:04
라인
K-Pharma Academy promotes Korean-Latin American ties
The Korea Health Industry Development Institute (KHIDI) completed its annua...
by Constance Williams  |  2017-04-10 15:40
라인
Hanmi’s osteoporosis therapy combines Evista with vitamin D
Hanmi Pharm has released a complex drug by combining Evista (compound: Ralo...
by Lee Hye-seon  |  2017-04-10 11:59
라인
Daewoong releases generic of cognition-enhancing Gliatilin for export
Daewoong Pharm, which handed over the domestic selling right of Gliatilin, ...
by Lee Hye-seon  |  2017-04-07 14:53
라인
Lilly’s new drug marks progress for treating soft tissue sarcoma
Last year, the U.S. and European food and drug agencies granted approval to...
by Marian Chu  |  2017-04-06 10:56
라인
LG Chem 'targets sales of $2.2-bil. in life science by 2025'
LG Chem plans to invest 1 trillion won ($890 million) into research and dev...
by Lee Hye-seon  |  2017-04-05 17:04
여백
여백
여백
Back to Top